Abstract:Objectives: The clinical experience with tissue-engineered tracheal grafts (TETGs) has been fraught with graft stenosis and delayed epithelialization. A mouse model of orthotopic replacement that recapitulates the clinical findings would facilitate the study of the cellular and molecular mechanisms underlying graft stenosis. Methods: Electrospun nanofiber tracheal scaffolds were created using nonresorbable (polyethylene terephthalate + polyurethane) and co-electrospun resorbable (polylactide-co-caprolactone/polyglycolic acid) polymers (n = 10/group). Biomechanical testing was performed to compare load displacement of nanofiber scaffolds to native mouse tracheas. Mice underwent orthotopic tracheal replacement with syngeneic grafts (n = 5) and nonresorbable (n = 10) and resorbable (n = 10) scaffolds. Tissue at the anastomosis was evaluated using hematoxylin and eosin (H&E), K5+ basal cells were evaluated with the help of immunofluorescence testing, and cellular infiltration of the scaffold was quantified. Micro computed tomography was performed to assess graft patency and correlate radiographic and histologic findings with respiratory symptoms. Results: Synthetic scaffolds were supraphysiologic in compression tests compared to native mouse trachea ( P < .0001). Nonresorbable scaffolds were stiffer than resorbable scaffolds ( P = .0004). Eighty percent of syngeneic recipients survived to the study endpoint of 60 days postoperatively. Mean survival with nonresorbable scaffolds was 11.40 ± 7.31 days and 6.70 ± 3.95 days with resorbable scaffolds ( P = .095). Stenosis manifested with tissue overgrowth in nonresorbable scaffolds and malacia in resorbable scaffolds. Quantification of scaffold cellular infiltration correlated with length of survival in resorbable scaffolds (R 2 = 0.95, P = .0051). Micro computed tomography demonstrated the development of graft stenosis at the distal anastomosis on day 5 and progressed until euthanasia was performed on day 11. Conclusion: Graft stenosis seen in orthotopic tracheal replacement with synthetic tracheal scaffolds can be modeled in mice. The wide array of lineage tracing and transgenic mouse models available will permit future investigation of the cellular and molecular mechanisms underlying TETG stenosis.

A tracheal transplantation model for studying the impact of ventilation

Suppression of the Obliteration Process by Ventilation in a Mouse Orthotopic Tracheal Transplantation Model.

Introduction of Modified Cervical Cardiac Transplant Model in Mice.

A Novel Rat Lung Transplantation Model Using Veno-Arterial Extracorporeal Membrane Oxygenation Support

Orthotopic Tracheal Transplantation in the Murine Model1

The relation between epithelial-mesenchymal transition and bronchiolitis obliterans post lung transplantation in rats

A Novel MyD88 Inhibitor Attenuates Allograft Rejection after Heterotopic Tracheal Transplantation in Mice

Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation.

The Role of Epithelial-Mesenchymal Transition in the Post-Lung Transplantation Bronchiolitis Obliterans

Role of Reepithelization in the Development of Obliterative Airway Disease after Lung Transplantation

Feasibility of tracheal reconstruction using Silicone-Stented aortic allografts

The Improvement of Orthotopic Left Pulmonary Allograft Model in Rats

Mouse Model of Tracheal Replacement With Electrospun Nanofiber Scaffolds

The Autotransplanted Tracheas Wrapped in United Muscle Flap of the Neck:An Experiment

The Role of HIF-1α-VEGF Pathway in Bronchiolitis Obliterans after Lung Transplantation

Establishment and Improvement of Rat Allograft Orthotopic Left Lung Transplantation Model

A Simple Cuff Technique for Murine Left Lung Transplantation

Long-term pulmonary function and pathological changes of orthotopic left lung allografts in rats

SUCCESSFUL CANINE TRACHEAL ALLOTRANSPLANTATION BY TRITON TREATMENT

Revolutionizing tracheal reconstruction: innovations in vascularized composite allograft transplantation

Human Tracheal Allotransplant with Greater Omentum for Revascularization.